Keyphrases
Anti-peptide Antibody
100%
Pseudomonas Aeruginosa Infection
100%
Exotoxin A
100%
Pseudomonas Aeruginosa (P. aeruginosa)
27%
Epitope
18%
Synthetic Peptides
18%
Producing Strain
18%
Specific Antibodies
9%
Microorganisms
9%
Immunization
9%
Mouse Model
9%
Virulence Factors
9%
Thermal Injury
9%
Antibiotics
9%
Amino Acid Residues
9%
Amino Acids
9%
Major Trauma
9%
Fatal Infection
9%
Cytotoxic Activity
9%
Antibiotic Treatment
9%
Leucine
9%
Amikacin
9%
Opportunistic Pathogens
9%
Trauma Injuries
9%
3T3 Fibroblasts
9%
Passive Immunization
9%
Translocation Domain
9%
Active Immunity
9%
P. Aeruginosa Infection
9%
Compromised Host
9%
Pharmacology, Toxicology and Pharmaceutical Science
Pseudomonas Infection
100%
Exotoxin
100%
Pseudomonas aeruginosa
36%
Infection
27%
Antibodies
18%
Amino Acid
18%
Epitope
18%
Synthetic Peptide
18%
Injury
9%
Infectious Agent
9%
Mouse Model
9%
Thermal Injury
9%
Virulence Factor
9%
Leucine
9%
Amikacin
9%
Immunocompromised Patient
9%
Microorganism
9%
Cytotoxicity
9%
Immunology and Microbiology
Pseudomonas aeruginosa
100%
Immunology
100%
Exotoxin
100%
Epitope
18%
Antibodies
18%
Infectious Agent
9%
Mouse Model
9%
Virulence Factor
9%
Cytotoxicity
9%
Immunocompromised Patient
9%
Active Immunization
9%
Fibroblast
9%
Microorganism
9%